NPI: 1912527193 · OSHKOSH, WI 54904 · General Acute Care Hospital · NPI assigned 04/17/2020
Authorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | MCCULLOUGH, MICHAEL (CFO) |
| Parent Organization | ASCENSION NE WISCONSIN, INC |
| NPI Enumeration Date | 04/17/2020 |
Other providers sharing the same authorized official: MCCULLOUGH, MICHAEL
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 31,827 | $488K |
| 2021 | 63,488 | $1.02M |
| 2022 | 63,611 | $1.10M |
| 2023 | 50,405 | $911K |
| 2024 | 34,178 | $796K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,766 | 6,634 | $482K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,264 | 2,904 | $459K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,909 | 5,731 | $365K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,664 | 5,236 | $334K |
| 80053 | Comprehensive metabolic panel | 13,372 | 10,422 | $212K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,136 | 1,750 | $147K |
| 90834 | Psychotherapy, 45 minutes with patient | 3,305 | 1,695 | $134K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,065 | 1,810 | $134K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,650 | 1,460 | $101K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,684 | 1,411 | $101K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,326 | 1,040 | $94K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,245 | 942 | $84K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,252 | 4,301 | $74K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,988 | 4,730 | $72K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,670 | 1,373 | $69K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 716 | 603 | $65K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 964 | 604 | $59K |
| 80061 | Lipid panel | 4,661 | 4,105 | $49K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,632 | 1,407 | $48K |
| G0378 | Hospital observation service, per hour | 1,697 | 1,108 | $48K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 939 | 691 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,872 | 6,242 | $43K |
| 87634 | 773 | 661 | $41K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,290 | 1,017 | $41K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,563 | 1,356 | $40K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 211 | 193 | $40K |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 4,461 | 3,339 | $37K |
| 80306 | 2,623 | 1,913 | $37K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,671 | 1,446 | $35K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 459 | 369 | $35K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,009 | 639 | $27K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,089 | 987 | $25K |
| 84484 | 2,885 | 2,119 | $25K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 335 | 298 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 334 | 306 | $22K |
| 90791 | Psychiatric diagnostic evaluation | 396 | 290 | $22K |
| 81001 | 6,024 | 4,690 | $22K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,065 | 853 | $20K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 601 | 487 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,540 | 2,072 | $19K |
| 0240U | 470 | 376 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,150 | 1,894 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 237 | 189 | $15K |
| 71046 | Radiologic examination, chest; 2 views | 1,012 | 882 | $14K |
| 83690 | 2,864 | 2,250 | $14K | |
| 86803 | 1,192 | 990 | $14K | |
| 81025 | 1,567 | 1,212 | $14K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,000 | 782 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 968 | 832 | $13K |
| 85027 | 3,102 | 2,346 | $12K | |
| 85610 | 3,296 | 2,392 | $12K | |
| 82728 | 957 | 826 | $11K | |
| 84703 | 1,725 | 1,369 | $11K | |
| 84439 | 1,237 | 1,000 | $11K | |
| 83735 | 2,314 | 1,683 | $10K | |
| H0022 | Alcohol and/or drug intervention service (planned facilitation) | 549 | 303 | $10K |
| 82947 | 1,097 | 646 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 549 | 436 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 124 | 99 | $10K |
| 99001 | 1,597 | 1,323 | $10K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 548 | 485 | $9K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 536 | 473 | $8K |
| 80143 | 722 | 561 | $8K | |
| 83880 | 423 | 356 | $8K | |
| 86780 | 850 | 686 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,698 | 4,479 | $8K |
| 82962 | 929 | 566 | $8K | |
| 82607 | 645 | 561 | $7K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 112 | 105 | $7K |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 1,218 | 781 | $7K |
| 80179 | 688 | 539 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 358 | 304 | $7K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 1,041 | 292 | $7K |
| 74018 | 402 | 320 | $6K | |
| 87070 | 949 | 817 | $6K | |
| 82077 | 781 | 562 | $6K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 205 | 165 | $6K |
| 90832 | Psychotherapy, 30 minutes with patient | 247 | 128 | $6K |
| 86140 | 1,474 | 1,134 | $6K | |
| 87340 | 793 | 631 | $6K | |
| 83605 | 760 | 591 | $6K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 505 | 176 | $6K |
| 80076 | 643 | 540 | $6K | |
| 87081 | 578 | 505 | $6K | |
| 84702 | 330 | 208 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 77 | 70 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 375 | 309 | $5K |
| 87653 | 164 | 150 | $5K | |
| 85379 | 725 | 604 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 63 | 53 | $5K |
| 85007 | 1,224 | 931 | $5K | |
| 87077 | 485 | 413 | $5K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 127 | 105 | $4K |
| 82565 | 599 | 494 | $4K | |
| 87186 | 680 | 573 | $4K | |
| 87210 | 747 | 642 | $4K | |
| 84153 | 290 | 259 | $4K | |
| 84481 | 344 | 295 | $4K | |
| 86850 | 945 | 660 | $4K | |
| 84450 | 599 | 523 | $4K | |
| 83550 | 597 | 526 | $4K | |
| 83655 | 305 | 273 | $3K | |
| 83540 | 778 | 679 | $3K | |
| 82043 | 714 | 654 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,010 | 851 | $3K |
| 82950 | 259 | 218 | $3K | |
| 86762 | 279 | 206 | $3K | |
| 87205 | 938 | 807 | $3K | |
| 86900 | 942 | 654 | $3K | |
| 84460 | 816 | 718 | $3K | |
| 85730 | 880 | 688 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 55 | 49 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,244 | 4,042 | $2K |
| 94729 | 139 | 105 | $2K | |
| 71045 | Radiologic examination, chest; single view | 3,638 | 2,953 | $2K |
| 86901 | 939 | 654 | $2K | |
| 73564 | 160 | 126 | $2K | |
| 86787 | 304 | 227 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 279 | 124 | $2K |
| 73030 | 128 | 112 | $2K | |
| 83970 | 66 | 51 | $2K | |
| 97162 | 37 | 29 | $1K | |
| 82465 | 142 | 118 | $1K | |
| 85652 | 772 | 582 | $1K | |
| 99215 | Prolong outpt/office vis | 20 | 17 | $1K |
| 94726 | 139 | 105 | $1K | |
| 81003 | 433 | 390 | $1K | |
| 85018 | 372 | 313 | $1K | |
| 93975 | 21 | 14 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 15,470 | 11,458 | $1K |
| 84466 | 106 | 85 | $948.59 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,515 | 2,635 | $911.64 |
| 94060 | 30 | 25 | $906.63 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 460 | 193 | $896.92 |
| 82550 | 207 | 168 | $886.32 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14 | 13 | $800.69 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 254 | 148 | $665.18 |
| 93017 | 12 | 12 | $641.80 | |
| 97597 | 21 | 14 | $491.92 | |
| 83718 | 64 | 54 | $457.53 | |
| 84100 | 119 | 79 | $449.55 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 19 | 15 | $445.99 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,141 | 1,542 | $413.08 |
| 96376 | 1,037 | 645 | $400.61 | |
| 93226 | 19 | 14 | $398.39 | |
| 73610 | 95 | 88 | $353.63 | |
| 84145 | 23 | 12 | $348.19 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,673 | 1,298 | $341.99 |
| 86038 | 32 | 27 | $318.21 | |
| 73502 | 12 | 12 | $299.36 | |
| 82746 | 15 | 14 | $192.04 | |
| 87147 | 53 | 41 | $172.48 | |
| 73110 | 33 | 30 | $171.46 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,215 | 3,050 | $170.19 |
| 90715 | 29 | 24 | $169.50 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,162 | 717 | $125.81 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 15 | 14 | $116.38 |
| 94200 | 31 | 12 | $109.86 | |
| 84550 | 26 | 24 | $102.17 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 70 | 49 | $96.96 |
| 82040 | 28 | 25 | $91.08 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,401 | 1,545 | $84.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,708 | 1,720 | $79.55 |
| 73630 | 94 | 78 | $78.20 | |
| 82247 | 23 | 12 | $75.26 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 16 | 12 | $57.44 |
| 82570 | 14 | 13 | $56.13 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,582 | 1,080 | $44.24 |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,426 | 937 | $44.18 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,522 | 3,212 | $40.44 |
| 84156 | 13 | 12 | $39.51 | |
| J2060 | Injection, lorazepam, 2 mg | 215 | 160 | $38.47 |
| 73130 | 29 | 26 | $20.13 | |
| A9270 | Non-covered item or service | 4,402 | 3,143 | $14.19 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 385 | 287 | $4.62 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 880 | 618 | $3.00 |
| J2704 | Injection, propofol, 10 mg | 1,301 | 1,012 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 45 | 41 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 212 | 134 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 706 | 560 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 38 | 29 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 65 | 12 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 34 | 24 | $0.00 |